Elevance Health Inc (ELV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,004,000 | 5,888,000 | 5,011,000 | 3,413,000 | 1,779,000 |
| Depreciation Amortization | 462,000 | 1,675,000 | 1,202,000 | 751,000 | 358,000 |
| Income taxes - deferred | -255,000 | -115,000 | -183,000 | -181,000 | -96,000 |
| Accounts receivable | -29,000 | -2,510,000 | -678,000 | -662,000 | -1,348,000 |
| Accounts payable and accrued liabilities | 306,000 | 2,411,000 | 1,588,000 | 1,548,000 | 1,092,000 |
| Other Working Capital | 4,054,000 | 423,000 | 3,561,000 | 764,000 | 452,000 |
| Other Operating Activity | -73,000 | 627,000 | -584,000 | -640,000 | 304,000 |
| Operating Cash Flow | $6,469,000 | $8,399,000 | $9,917,000 | $4,993,000 | $2,541,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 204,000 | -301,000 | -677,000 | -620,000 | -441,000 |
| PPE Investments | -301,000 | -1,152,000 | -854,000 | -549,000 | -254,000 |
| Net Acquisitions | -1,638,000 | -649,000 | 6,983,000 | -609,000 | -61,000 |
| Purchase Of Investment | -7,443,000 | -24,946,000 | -19,612,000 | -13,253,000 | -5,050,000 |
| Sale Of Investment | 6,022,000 | 22,608,000 | 9,402,000 | 11,487,000 | 4,256,000 |
| Other Investing Activity | -28,000 | -120,000 | -91,000 | -58,000 | -28,000 |
| Investing Cash Flow | $-3,184,000 | $-4,560,000 | $-4,849,000 | $-3,602,000 | $-1,578,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -171,000 | 2,600,000 | 2,231,000 | 2,712,000 | 970,000 |
| Debt Issued | 2,574,000 | 3,071,000 | 1,661,000 | 1,550,000 | 225,000 |
| Debt Repayment | -1,908,000 | -1,899,000 | -982,000 | -943,000 | -14,000 |
| Common Stock Issued | 43,000 | 182,000 | 152,000 | 116,000 | 76,000 |
| Common Stock Repurchased | -622,000 | -2,316,000 | -1,748,000 | -1,169,000 | -545,000 |
| Dividend Paid | -351,000 | -1,229,000 | -924,000 | -618,000 | -309,000 |
| Other Financing Activity | -96,000 | -1,727,000 | -1,450,000 | -1,453,000 | -81,000 |
| Financing Cash Flow | $-531,000 | $-1,318,000 | $-1,060,000 | $195,000 | $322,000 |
| Exchange Rate Effect | 1,000 | -14,000 | -16,000 | -10,000 | -4,000 |
| Beginning Cash Position | 7,387,000 | 4,880,000 | 4,880,000 | 4,880,000 | 4,880,000 |
| End Cash Position | 10,142,000 | 7,387,000 | 8,872,000 | 6,456,000 | 6,161,000 |
| Net Cash Flow | $2,755,000 | $2,507,000 | $3,992,000 | $1,576,000 | $1,281,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,469,000 | 8,399,000 | 9,917,000 | 4,993,000 | 2,541,000 |
| Capital Expenditure | -301,000 | -1,152,000 | -854,000 | -549,000 | -254,000 |
| Free Cash Flow | 6,168,000 | 7,247,000 | 9,063,000 | 4,444,000 | 2,287,000 |